Jul. 19, 2022
EU-OPENSCREEN is one of the 10 partners in the AI4LIFE consortium coordinated by Euro-BioImaging ERIC, bringing together leading AI/ML researchers and developers of popular open source image analysis…
Jul. 6, 2022
Get free access to our screening and medicinal chemistry services for your Monkeypox research project. ISIDORe just launched a call for transnational access for projects focusing on Monkeypox…
Jul. 4, 2022
We are pleased to announce that from July 1st, 2022, Sweden expands the circle of EU-OPENSCREEN member countries from 9 to 10 countries. As a partner of EU-OPENSCREEN since the preparatory phase, our…
Jun. 30, 2022
The EU-OPENSCREEN interactive Annual Report 2021 is now online. Enjoy reading about our developments and key achievements in 2021.
Jun. 24, 2022
Would you like to learn more about the different funding opportunites within ISIDORe and the structure and research focus of ISIDORe? Then do not miss the upcoming webinar providing you with…
Jun. 8, 2022
Within the recently launched ISIDORe transnational access call for proposals focusing on SARS-CoV-2 research EU-OPENSCREEN offers free of charge access opportunities to interested researchers to…
May. 23, 2022
Our medicinal chemistry partner site, the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, Germany, has collaborated with 17 leading research institutions and pharma companies…
May. 12, 2022
What´s in for the ERIC Forum Community?
Mar. 31, 2022
Once again our very successful training for compound managers took place at our partner site IMG in Prague in March 2022.
Mar. 14, 2022
Position of ERIC Forum Executive Board on the developments in Ukraine
Page 1 of 13.